B. Masereel

发表

A harmine‐derived beta‐carboline displays anti‐cancer effects in vitro by targeting protein synthesis

R. Kiss, J. Pelletier, J. Wouters, 2017, European journal of pharmacology.

Prostanoids as pharmacological targets in COPD and asthma.

B. Masereel, S. Rolin, J. Dogné, 2006, European journal of pharmacology.

Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-kappaB activation.

J. Wouters, E. Dejardin, J. Piette, 2010, Biochemical pharmacology.

NF-kappaB inducing kinase (NIK) inhibitors: identification of new scaffolds using virtual screening.

J. Piette, B. Masereel, Jérémie Mortier, 2010, Bioorganic & medicinal chemistry letters.

Anti-virulence strategy against Brucella suis: synthesis, biological evaluation and molecular modeling of selective histidinol dehydrogenase inhibitors.

P. Joseph, J. Winum, J. Montero, 2011, Organic & biomolecular chemistry.

Targeting tumor-associated carbonic anhydrase IX in cancer therapy.

C. Supuran, B. Masereel, J. Dogné, 2006, Trends in pharmacological sciences.

Coumarin and isocoumarin as serine protease inhibitors.

B. Masereel, R. Frédérick, L. Pochet, 2004, Current pharmaceutical design.

Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.

P. Kolh, P. Segers, B. Lambermont, 2006, Prostaglandins & other lipid mediators.

3,6-disubstituted coumarins as mechanism-based inhibitors of thrombin and factor Xa.

J. de Ruyck, J. Wouters, B. Masereel, 2005, Journal of medicinal chemistry.

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

C. Uyttenhove, J. Wouters, B. Masereel, 2012, Proceedings of the National Academy of Sciences.

Dose assessment of SiC nanoparticle dispersions during in vitro assays

B. Masereel, O. Toussaint, S. Lucas, 2013, Journal of nanoparticle research.

Fate of SiC and TiC nanoparticle dispersions in human reconstituted gastric fluid

B. Masereel, O. Toussaint, S. Lucas, 2012 .

Isosterism among analogues of torasemide: conformational, electronic and lipophilic properties.

J. Wouters, B. Masereel, J. Dogné, 2000, European journal of medicinal chemistry.

Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need

B. Masereel, J. Dogné, C. Bouvy, 2019, Clinical chemistry and laboratory medicine.

Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives.

J. Wouters, C. Meinguet, B. Masereel, 2011, European journal of medicinal chemistry.

Novel trisubstituted harmine derivatives with original in vitro anticancer activity.

R. Kiss, J. Wouters, A. Backlund, 2012, Journal of medicinal chemistry.

New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.

C. Supuran, A. Scozzafava, P. Depreux, 2013, Bioorganic & medicinal chemistry.

An overview of inhibitors of Na(+)/H(+) exchanger.

B. Masereel, L. Pochet, D. Laeckmann, 2003, European journal of medicinal chemistry.

Antibody immobilization on gold nanoparticles coated layer-by-layer with polyelectrolytes

O. Feron, B. Masereel, C. Bouzin, 2011 .

Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs.

C. Supuran, B. Masereel, J. Dogné, 2008, Journal of medicinal chemistry.

Surface properties and cell adhesion onto allylamine-plasma and amine-plasma coated glass coverslips

O. Feron, B. Masereel, T. Borght, 2011, Journal of materials science. Materials in medicine.

PVD Synthesis and Transfer into Water-Based Solutions of Functionalized Gold Nanoparticles

O. Feron, B. Masereel, T. Borght, 2009 .

Synthesis, crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles.

J. Frère, M. Galleni, J. Wouters, 2012, European journal of medicinal chemistry.

Synthesis, crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles.

J. Frère, M. Galleni, J. Wouters, 2012, European journal of medicinal chemistry.

Evidence for a Neuroprotective Effect of Pyrid‐3‐yl‐sulphonylurea in Photochemically Induced Focal Ischaemia in Rats: Magnetic Resonance Imaging Evaluation

C. Ritter, R. Demeure, B. Masereel, 1999, The Journal of pharmacy and pharmacology.

Synthesis and pharmacology of pyrid-3-ylsulfonylcyanoguanidines as diuretics

P. Tullio, B. Masereel, J. Liégeois, 1995 .

Chemical reactivity of plasma polymerized allylamine (PPAA) thin films on Au and Si: Study of the thickness influence and aging of the films

O. Feron, F. Rossi, B. Masereel, 2011 .

Carbonic anhydrase inhibitors as anticonvulsant agents.

C. Supuran, B. Masereel, J. Dogné, 2007, Current topics in medicinal chemistry.

Limited inflammatory response in rats after acute exposure to a silicon carbide nanoaerosol

B. Masereel, J. Dogné, O. Toussaint, 2015, Journal of Nanoparticle Research.

BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase.

L. de Leval, B. Masereel, S. Rolin, 2011, Prostaglandins & other lipid mediators.

Therapeutic potential of thromboxane inhibitors in asthma

B. Masereel, S. Rolin, J. Dogné, 2002, Expert opinion on investigational drugs.

Thromboxane A2 Inhibition

B. Masereel, J. Dogné, P. Benoit, 2012, American journal of respiratory medicine : drugs, devices, and other interventions.

Production and preliminary characterization of DC plasma polymerized allylamine film (PPAA) by NRA, ERD and XPS

O. Feron, B. Masereel, T. Borght, 2008 .

A comparison of six major platelet functional tests to assess the impact of carbon nanomaterials on platelet function: A practical guide

B. Masereel, S. Rolin, J. Dogné, 2014, Nanotoxicology.

BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2alphain vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents.

D. Praticò, B. Masereel, S. Rolin, 2007, Prostaglandins & other lipid mediators.

Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors.

B. Masereel, S. Rolin, J. Dogné, 2004, Prostaglandins & other lipid mediators.

The Mode of Action of Diuretics

O. Eidelman, B. Masereel, E. Lohrmann, 1991 .

AB0223 Evaluation of classical nsaids and cox-2 selective inhibitors on purified ovine enzymes and human whole blood

B. Masereel, J. Dogné, Y. Henrotin, 2001, Prostaglandins, leukotrienes, and essential fatty acids.

Na+,2Cl-,K+ cotransport system as a marker of antihypertensive activity of new torasemide derivatives.

B. Masereel, B. Pirotte, P. Parenti, 1992, European journal of pharmacology.

Design, Synthesis and Biological Activity of a Series of Torasemide Derivatives, Potent Blockers of the Na+ 2Cl− K+ Co‐transporter: In‐vitro Study

B. Masereel, E. Lohrmann, R. Greger, 1992, The Journal of pharmacy and pharmacology.

Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig.

P. Kolh, P. Segers, B. Lambermont, 2005, Thrombosis research.

Dispersion of multi-walled carbon nanotubes in biocompatible dispersants

B. Masereel, S. Rolin, J. Delhalle, 2010 .

In Vitro and in Vivo Pharmacological Characterization of BM-613 [N-n-Pentyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a Novel Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist

B. Masereel, S. Rolin, J. Dogné, 2005, Journal of Pharmacology and Experimental Therapeutics.

In vitro and in vivo pharmacological characterization of BM-613, a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist

B. Masereel, S. Rolin, J. Dogné, 2004 .

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

P. Kolh, P. Segers, L. de Leval, 2004, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological characterization of BM-573, a novel thromboxane A 2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time

P. Kolh, P. Segers, B. Masereel, 2004 .

Effects of endotoxic shock on right ventricular systolic function and mechanical efficiency.

P. Kolh, P. Segers, B. Lambermont, 2003, Cardiovascular research.

2,4,7‐Trimethyl‐2,3‐dihydro‐4H‐pyrido[4,3‐e]‐1,2,4‐thiadiazinium 1,1‐Dioxide Iodide

P. Tullio, O. Diouf, B. Masereel, 1995 .

Anticonvulsant Activity of Pyrid‐3‐yl‐Sulfonyl Ureas and Thioureas

J. Poupaert, B. Masereel, J. Dogné, 1997, Epilepsia.

Bioavailability and anticonvulsant activity of 2-cyanoguanidinophenytoin, a structural analogue of phenytoin.

G. Scriba, B. Masereel, B. Gallez, 1996, Journal of pharmaceutical sciences.

Synthesis and biological evaluation of aroylguanidines related to amiloride as inhibitors of the human platelet Na(+)/H(+) exchanger.

B. Masereel, D. Laeckmann, C. Prosperi-Meys, 2002, Bioorganic & medicinal chemistry.

Synthesis and pharmacology of pyrid-3-yl sulfonylureas and thioureas as astrocytic Na+ 2Cl- K+ cotransporter inhibitors

P. Tullio, P. Renard, B. Masereel, 1994 .

In vitro and in vivo effects of new insulin releasing agents.

B. Masereel, B. Pirotte, M. Antoine, 2002, Biochemical pharmacology.

Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.

B. Norberg, J. Wouters, B. Masereel, 2000, Acta crystallographica. Section C, Crystal structure communications.

Thromboxane A2 Receptor Antagonism in Man and Rat by a Sulphonylcyanoguanidine (BM‐144) and a Sulphonylurea (BM‐500)

B. Masereel, L. Pochet, J. Fontaine, 1999, The Journal of pharmacy and pharmacology.

Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles.

B. Masereel, S. Rolin, J. Dogné, 2001, Prostaglandins, leukotrienes, and essential fatty acids.

Synthesis, structural characterization and thromboxane A2 receptor antagonistic activity of 3-substituted 2-[(arylsulfonyl)imino]-2,3-dihydrothiazolyl derivatives

B. Masereel, J. Dogné, J. Leger, 1999 .

Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitor.

P. Kolh, P. Chiap, B. Lambermont, 2006, Cardiovascular drug reviews.

Insulinotropic effect of new glibenclamide isosteres.

B. Masereel, L. Pochet, M. Dunne, 1999, The Journal of pharmacology and experimental therapeutics.

Insulinotropic Effect of New Glibenclamide Isosteres 1

B. Masereel, L. Pochet, M. Dunne, 1999 .

Recent developments of thromboxane modulators

B. Masereel, J. Dogné, J. Delarge, 2001 .

Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A.

J. Wouters, C. Meinguet, B. Masereel, 2013, Bioorganic & medicinal chemistry letters.

Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

J. Frère, M. Galleni, B. Norberg, 2011, Bioorganic & medicinal chemistry.

Synthesis, molecular modelling and enzymatic evaluation of (+/-)3,5-diphenyl-2-thioxoimidazolidin-4-ones as new potential cyclooxygenase inhibitors.

B. Masereel, S. Rolin, C. Michaux, 2006, Bioorganic & medicinal chemistry.

Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62.

B. Masereel, A. Herchuelz, B. Pirotte, 1996, The Journal of pharmacology and experimental therapeutics.

Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.

J. Wouters, B. Masereel, B. J. Van den Eynde, 2011, Journal of medicinal chemistry.

Carbon nanoparticles synthesized by sputtering and gas condensation inside a nanocluster source of fixed dimension

O. Feron, B. Masereel, T. Borght, 2011 .

Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation.

M. Merville, V. Benoît, B. Masereel, 2003, Prostaglandins, leukotrienes, and essential fatty acids.

Effect of a Novel Thromboxane A2 Inhibitor on Right Ventricular-Arterial Coupling in Endotoxic Shock

P. Kolh, P. Segers, B. Lambermont, 2004, Shock.

New trends in thromboxane and prostacyclin modulators.

B. Masereel, J. Dogné, J. David, 2000, Current medicinal chemistry.

Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.

B. Masereel, C. Charlier, L. Pochet, 2005, Current medicinal chemistry.

Synthesis and structural studies of a new class of heterocyclic compounds: 1,2,4-Pyridothiadiazine 1,1-dioxides, pyridyl analogues of 1,2,4-benzothiadiazine 1,1-dioxides

P. Tullio, O. Diouf, B. Masereel, 1995 .

Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation.

O. Diouf, P. Renard, B. Masereel, 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers?

B. Masereel, A. Herchuelz, B. Pirotte, 1993, Journal of medicinal chemistry.

Synthesis and Biological Evaluation of New 3‐Aralkylamino‐2‐aryl‐2H‐1,2,4‐pyridothiadiazine 1,1‐dioxides as Potential CCK‐Receptor Ligands

P. Tullio, O. Diouf, P. Renard, 1997, The Journal of pharmacy and pharmacology.

Synthesis and Structural Studies of a New Class of Heterocyclic Compounds: 1,2,4-Pyridothiadiazine 1,1-Dioxides, Pyridyl Analogues of 1,2,4-Benzothiadiazine 1,1-Dioxides.

P. Tullio, O. Diouf, B. Masereel, 2010 .

3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships.

O. Diouf, B. Masereel, B. Pirotte, 1996, Journal of medicinal chemistry.

Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity.

J Delarge, B. Masereel, B. Pirotte, 1996, Journal of medicinal chemistry.

Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.

C. Supuran, A. Scozzafava, B. Masereel, 2004, Bioorganic & medicinal chemistry.

3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo

J. Foidart, A. Noël, B. Masereel, 2003, British Journal of Cancer.

Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins.

C. Supuran, A. Scozzafava, B. Masereel, 2010, Journal of medicinal chemistry.

Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.

C. Supuran, A. Scozzafava, B. Masereel, 2002, Journal of medicinal chemistry.

Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors.

B. Masereel, C. Bertolla, J. Dogné, 2008, Journal of medicinal chemistry.

Specific inhibitors of human leukocyte elastase

B. Masereel, B. Pirotte, L. Pochet, 2000 .

Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase.

G. Dive, J. Wouters, B. Masereel, 2000, Bioorganic & medicinal chemistry.

Esters and Amides of 6‐(Chloromethyl)‐2‐oxo‐2H‐1‐benzopyran‐3‐ carboxylic Acid as Inhibitors of α‐Chymotrypsin: Significance of the “Aromatic” Nature of the Novel Ester‐Type Coumarin for Strong Inhibitory Activity.

P. Tullio, B. Masereel, B. Pirotte, 1996 .

Mechanism-based thrombin inhibitors: design, synthesis, and molecular docking of a new selective 2-oxo-2H-1-benzopyran derivative.

J. Wouters, B. Masereel, C. Charlier, 2007, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of a new targeted drug carrier system: beta-cyclodextrin coupled to oxytocin.

B. Masereel, C. Bertolla, S. Rolin, 2008, Bioorganic & medicinal chemistry letters.

Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors.

C. Supuran, A. Scozzafava, P. Depreux, 2010, Bioorganic & medicinal chemistry.

"Fries like" rearrangement: a novel and efficient method for the synthesis of 6-acyl-2(3H)-benzoxazolones and 6-acyl-2(3H)-benzothiazolones

J. Poupaert, D. Lesieur, B. Masereel, 1998 .

A new potential anti‐cancer beta‐carboline derivative decreases the expression levels of key proteins involved in glioma aggressiveness: A proteomic investigation

Y. Vander Heyden, K. De Braekeleer, J. Wouters, 2019, Drug development research.

Synthesis and biological evaluation of sulfonylcyanoguanidines and sulfonamidonitroethylenes as bioisosteres of hypoglycemic sulfonylureas

P. Tullio, B. Masereel, J. Dogné, 1997 .

Preparation and characterization of a new harmine-based antiproliferative compound in complex with cyclodextrin: Increasing solubility while maintaining biological activity.

J. Wouters, C. Meinguet, B. Masereel, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitors.

C. Supuran, J. Wouters, B. Masereel, 2009, European journal of medicinal chemistry.

Effects of the dispersion methods in Pluronic F108 on the size and the surface composition of MWCNTs and their implications in toxicology assessment

B. Masereel, J. Delhalle, Z. Mekhalif, 2011 .

Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.

J. Wouters, B. Masereel, R. Frédérick, 2014, European journal of medicinal chemistry.

Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

J. Frère, M. Galleni, J. Wouters, 2011, European journal of medicinal chemistry.

Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide.

J. Poupaert, B. Masereel, J. Stables, 1998, Journal of medicinal chemistry.

Torasemide Derivatives: New Perspectives

B. Masereel, 1993 .

Radioimmunotherapy with radioactive nanoparticles: First results of dosimetry for vascularized and necrosed solid tumors.

B. Masereel, T. Borght, S. Lucas, 2007, Medical physics.

A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors.

J. Wouters, B. Masereel, S. Rolin, 2003, European journal of medicinal chemistry.

P-glycoprotein inhibition by glibenclamide and related compounds

B. Masereel, A. Boom, R. Beauwens, 1999, Pflügers Archiv.

Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action.

C. Supuran, B. Masereel, J. Dogné, 2008, Current pharmaceutical design.

Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation.

P. Lambin, L. Dubois, A. Harris, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Carbonic Anhydrase Inhibitors: Binding of Indanesulfonamides to the Human Isoform II

C. Supuran, A. Scozzafava, B. Masereel, 2008, ChemMedChem.

Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors.

Johan Wouters, Bernard Masereel, Alessandro Cecchi, 2009, Bioorganic & medicinal chemistry.

Rectal Duplication: a Case Report

B. Masereel, K. Didden, P. Geyskens, 2013, Acta chirurgica Belgica.

3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties.

R. Kiss, J. Wouters, C. Meinguet, 2015, European journal of medicinal chemistry.

Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs?

Bernard Pirotte, Bernard Masereel, B. Masereel, 2009, Pharmacological research.

Pneumatosis Intestinalis Caused by Ischaemic Bowel: Report of Three Cases

B. Masereel, R. Visser, P. Geyskens, 2006, Acta chirurgica Belgica.

Comparison of several strategies for the deployment of a multivariate regression model on several handheld NIR instruments. Application to the quality control of medicines.

R. Marini, É. Ziemons, B. Masereel, 2022, Journal of pharmaceutical and biomedical analysis.

Can TiC nanoparticles produce toxicity in oral administration to rats?

B. Masereel, J. Dogné, O. Toussaint, 2014, Toxicology reports.

Novel inhibitors of the sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives.

B. Masereel, J. Liégeois, A. Herchuelz, 2001, European journal of medicinal chemistry.

Synthesis of Nimesulide Nanoparticles in the Microemulsion Epikuron/Isopropyl Myristate/Water/n-Butanol (or Isopropanol)

J. Nagy, B. Masereel, L. Jeunieau, 2001 .

Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.

B. Masereel, J. Liégeois, B Masereel, 1995, European journal of pharmacology.

Investigation of mechanism-based thrombin inhibitors: Implications of a highly conserved water molecule for the binding of coumarins within the S pocket.

J. Wouters, B. Masereel, C. Charlier, 2006, Bioorganic & medicinal chemistry letters.

Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.

C. Supuran, Alessandro Cecchi, J. Wouters, 2006, Journal of medicinal chemistry.

Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: structure-activity relationship and pharmacological evaluation.

C. Supuran, A. Scozzafava, D. Vullo, 2008, European journal of medicinal chemistry.

Exploration of the Binding Mode of Indanesulfonamides as Selective Inhibitors of Human Carbonic Anhydrase Type VII by Targeting Lys 91

C. Supuran, J. Wouters, B. Masereel, 2007, ChemMedChem.

Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials

Catherine Y. Marbehant, B. Masereel, S. Rolin, 2012, Nanotoxicology.

Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.

C. Supuran, A. Scozzafava, A. Innocenti, 2004, Bioorganic & medicinal chemistry letters.

Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.

C. Supuran, A. Scozzafava, J. Winum, 2007, Bioorganic & Medicinal Chemistry Letters.

Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor

J. Wouters, B. Masereel, J. Dogné, 2001, The Journal of pharmacy and pharmacology.

Radioimmunotherapy with radioactive nanoparticles: first results of dosimetry for vascularized and necrosed solid tumors.

B. Masereel, T. Vander Borght, S. Lucas, 2007, Medical physics.

Evaluation of the Inhibitory Activity on Serine and Aspartic Proteases of 4‐Amino‐4H‐1,2,4‐triazole and 5‐Aminothiazole Derivatives Structurally Related to β‐Lactam Antibiotics

B. Masereel, ANNE‐CÉCILE VILAIN, BERNARD PIROTTE, 1993, The Journal of pharmacy and pharmacology.

Recent advances in antiplatelet agents.

B. Masereel, J. Dogné, J. David, 2002, Current Medicinal Chemistry.

Monte Carlo Calculation of Radioimmunotherapy with 90Y-, 177Lu-, 131I-, 124I-, and 188Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts

Thierry Vander Borght, Carine Michiels, Bernard Masereel, 2015, Comput. Math. Methods Medicine.

New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators.

B. Masereel, J. Dogné, J. David, 2004, Current medicinal chemistry.

New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators.

P. Kolh, A. Casini, B. Lambermont, 2004, Current medicinal chemistry.

Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function.

P. Kolh, B. Masereel, S. Rolin, 2003, Prostaglandins, leukotrienes, and essential fatty acids.

A Sulphonylthiourea (BM 20) Related to Torasemide: a new Loop Diuretic with Relative Potassium‐sparing Properties

B. Masereel, B. Pirotte, G. Rorive, 1993, The Journal of pharmacy and pharmacology.

Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531.

P. Kolh, B. Masereel, S. Rolin, 2006, Cardiovascular drug reviews.

Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition.

J. Wouters, B. Masereel, S. Rolin, 2001, Bioorganic & medicinal chemistry letters.

On the use of radioisotopes to study the possible synthesis by magnetron sputtering of bimetallic nanoparticles

B. Masereel, U. Holzwarth, T. Borght, 2011 .

Effects of BM-573, a Novel Thromboxane A2 Inhibitor, on Pulmonary Hemodynamics in Endotoxic Shock

P. Kolh, B. Lambermont, B. Masereel, 2003, Archives of physiology and biochemistry.

Effects of U-46619 on Pulmonary Hemodynamics Before and After Administration of BM-573, a Novel Thromboxane A2 Inhibitor

P. Kolh, B. Lambermont, B. Masereel, 2003, Archives of physiology and biochemistry.

Development of a PIXE analysis method for the determination of the biopersistence of SiC and TiC nanoparticles in rat lungs

D. Lison, B. Masereel, O. Toussaint, 2012, Nanotoxicology.

Investigation of the inhibition mechanism of coumarins on chymotrypsin by mass spectrometry

B. Masereel, B. Pirotte, R. Frédérick, 2003 .

Effects of SiC nanoparticles orally administered in a rat model: biodistribution, toxicity and elemental composition changes in feces and organs.

B. Masereel, S. Rolin, J. Dogné, 2012, Toxicology and applied pharmacology.

Quantification of nanoparticles in aqueous food matrices using Particle-Induced X-ray Emission

Jorge Mejia, Olivier Toussaint, Tijani Tabarrant, 2012, Analytical and Bioanalytical Chemistry.

Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.

J. Wouters, B. Masereel, R. Frédérick, 2011, Bioorganic & medicinal chemistry.

Antibody-functionalized polymer-coated gold nanoparticles targeting cancer cells: an in vitro and in vivo study

Bernard Gallez, Davide Bonifazi, Thierry Vander Borght, 2012 .

BM-573, a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, Prevents Pig Myocardial Infarction Induced by Coronary Thrombosis

M Petein, P. Kolh, B. Lambermont, 2003, Journal of Pharmacology and Experimental Therapeutics.

A dual thromboxane inhibitor and thromboxane receptor antagonist prevents pig myocardial infarction induced by coronary thrombosis

P. Kolh, B. Lambermont, B. Masereel, 2003 .

Activity and inhibition mechanism of coumarin-based derivatives as protease inhibitor

B. Masereel, B. Pirotte, L. Pochet, 2000 .

Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.

J. Wouters, B. Masereel, L. Pochet, 1998, Journal of medicinal chemistry.

Structural Study of Pinacidil, a Potassium‐Channel Opener Belonging to the chemical class of N‐alkyl‐N″‐cyano‐N′‐pyridylguanidines

P. Tullio, B. Masereel, B. Pirotte, 1993 .

New developments on thromboxane modulators.

P. Kolh, B. Masereel, J. Dogné, 2004, Mini reviews in medicinal chemistry.

Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area.

C Michiels, B. Masereel, T. Vander Borght, 2010, Medical physics.

Synthesis, Structural Characterization and Thromboxane A2 Receptor Antagonistic Activity of 3-Substituted 2-[(Arylsulfonyl)imino]-2,3-dihydrothiazolyl Derivatives.

B. Masereel, J. Dogné, J. Leger, 1999 .

Differential toxicity of copper (II) oxide nanoparticles of similar hydrodynamic diameter on human differentiated intestinal Caco-2 cell monolayers is correlated in part to copper release and shape

C. Zouboulis, B. Masereel, O. Toussaint, 2012, Nanotoxicology.

Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.

C. Supuran, A. Scozzafava, A. Innocenti, 2008, Journal of medicinal chemistry.

Antagonism of the TXA2 receptor by seratrodast: a structural approach.

J. Wouters, B. Masereel, F. Durant, 1999, Bioorganic & medicinal chemistry letters.

Are stirring and sonication pre-dispersion methods equivalent for in vitro toxicology evaluation of SiC and TiC?

Olivier Toussaint, Joseph Delhalle, Jean-Pascal Piret, 2012, Journal of Nanoparticle Research.

Synthesis and structural studies of a new class of heterocyclic compounds: 1,2,4-Pyridothiadiazine 1,1-dioxides, pyridyl analogues of 1,2,4-benzothiadiazine 1,1-dioxides

P. Tullio, O. Diouf, B. Masereel, 1995 .

Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives

Isa, B. Masereel, J. Stables, 1998, Journal of medicinal chemistry.

Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg

A. Konnerth, B. Sakmann, P. Jonas, 1990, Pflügers Archiv.

Correction to Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins.

C. Supuran, A. Scozzafava, B. Masereel, 2015, Journal of medicinal chemistry.